| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |